Marc Beyer

Marc Beyer serves as Group Leader at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, holding the academic rank of Associate Professor. His research investigates bidirectional immune-brain interactions during aging and neurodegeneration, with emphasis on T cell and microglial mechanisms in Alzheimer's, Parkinson's, and post-COVID neurological complications.

Dr. Beyer's group pioneers single-cell multi-omic approaches including snRNA-seq, scATAC-seq, and spatial transcriptomics to decode cellular heterogeneity in neurodegenerative contexts. Key projects involve creating human brain cell atlases (DFG-NGS collaboration), characterizing dopaminergic neuron transcriptional changes in Parkinson's, and exploring 'innate immune memory' in microglia. The NeuroCOV initiative identifies peripheral blood immune signatures linked to long-term cognitive decline after SARS-CoV-2 infection.

Scientific Awards: No awards specified in source materials.

Dr. Beyer directs multiple high-impact projects including a large DZNE cohort study on peripheral immunity in early dementia and the European NeuroCOV consortium. These initiatives employ high-throughput single-cell analysis of PBMCs to develop biomarkers for early therapeutic intervention, though specific grant details and student mentorship records remain unlisted.

The research team operates from DZNE's Venusberg Campus facility, utilizing CRISPR-Cas9 lineage tracing (LINC mouse model), high-dimensional flow cytometry, and multimodal omics platforms to dissect neuroimmune crosstalk in physiological and pathological CNS states.